Magrolimab in Combination With Cytotoxic Chemotherapy in Advanced Urothelial Carcinoma

Clinical trial NCT05738161 · WITHDRAWN

Trial details

NCT number: NCT05738161
Sponsor: Insel Gruppe AG, University Hospital Bern
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Urothelial Carcinoma

Start date: 2023-06-21
Primary completion: 2024-02-27
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.